Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.90
+0.11 (0.05%)
AAPL  263.21
-1.14 (-0.43%)
AMD  201.63
+1.51 (0.75%)
BAC  52.63
-0.73 (-1.37%)
GOOG  304.85
+0.91 (0.30%)
META  646.33
+3.11 (0.48%)
MSFT  399.58
-0.02 (-0.01%)
NVDA  186.84
-1.13 (-0.60%)
ORCL  158.06
+1.89 (1.21%)
TSLA  414.89
+3.57 (0.87%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.